tweenvest

Appili Therapeutics Inc. (TSXV: APLI.H)

Health Care · Pharmaceuticals · CA

CA$0.01

0.00% today · -75.0% 1Y

Public summary
A free snapshot of Appili Therapeutics Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Appili Therapeutics Inc. (TSXV: APLI.H) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $464.39K and employs 7 people.

Over the last twelve months the share price has lost 75.0%, trading between 0.01 and 0.03.

Tweenvest scores Appili Therapeutics Inc. across four factors: quality 8/100, value 73/100. Its strongest factor is value.

APLI.H price history

Nov 20, 2025 · 0.03Weekly closes 0.01 – 0.03Nov 13, 2026 · 0.01

Key figures

Market cap
$464.39K
Revenue (TTM)
$198.12K
P/E
-0.12
EPS
-0.04
Dividend yield
—
Beta (5Y)
-0.02
52-week high
CA$0.03
52-week low
CA$0.01
Avg volume (3M)
—
Shares outstanding
132.37M
Employees
7
Next earnings
—

About Appili Therapeutics Inc.

Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.

ISIN
CA03783R1073
Founded
2015
Listed since
Jun 25, 2019
Exchange
TSX Venture Exchange
Currency
CAD
CompanyMarket capPriceDay
Ovation Science Inc.CNSX: OVAT$550.24KCA$0.02-33.33%
Access-Power & Co., Inc.OTCPK: ACCR$541.80K$0.00-5.06%
Aequus Pharmaceuticals Inc.TSXV: AQS$478.54KCA$0.010.00%
Pharmadrug Inc.CNSX: PHRX$470.87KCA$0.010.00%
Fabino Enterprises LimitedBSE: 543444$453.32KRs20.31+4.96%
MPS Pharmaa LimitedBSE: 531686$417.82KRs2.080.00%
Altamira Therapeutics Ltd.OTCPK: CYTO.F$404.66K$0.070.00%
LiveCare, Inc.OTCPK: LVCE$357.22K$0.010.00%

Browse every Pharmaceuticals company →